Zonisamide (Zonegran) is approved as adjunctive therapy for partial
seizures refractory to therapy with traditional anticonvulsants.
Rufinamide is a known interference of this assay. Useful for Monitoring
zonisamide therapy; recommended for all patients to ensure appropriate
dosing.
